Skip to main content

Multiple endocrine neoplasia type I Surgical therapy

  • Chapter
Endocrine Neoplasms

Part of the book series: Cancer Treatment and Research ((CTAR,volume 89))

Abstract

The therapy of MEN-I is multifaceted in that surgical treatment in the individual patient is dependent on the phenotypic expression at the time of diagnosis. In many patients, the first clinical expression of the syndrome is hyperparathyroidism (HPT). In others, it may be a combination of manifestations, including a functional endocrine pancreatic syndrome and HPT, or a combination of HPT and a pituitary tumor such as a prolactinoma. Occasionally, an MEN-I patient may present with clinical manifestations in all three organs simultaneously. This discussion will be limited to the surgical management of the parathyroid and pancreatic components of the syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Block MA. 1991. Familial hyperparathyroidism and hyperparathyroidism associated with multiple endocrine neoplasia syndrome. In Cady B, Rossi RL, eds. Surgery of the Thyroid and Parathyroid Glands, 3rd ed. Philadelphia: W.B. Saunders.

    Google Scholar 

  2. Lamers CB, Froeling PG. 1979. Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type 1 (MEA I). Am J Med 66:422–424.

    Article  PubMed  CAS  Google Scholar 

  3. Malmaeus J, Benson L, Johansson H, Ljunghall S, Rastad J, Akerstrom G, et al. 1986. Parathyroid surgery in the multiple endocrine neoplasia type 1 syndrome: Choice of surgical procedure. World J Surg 10:668–672.

    Article  PubMed  CAS  Google Scholar 

  4. Shepherd JJ. 1991. The natural history of multiple endocrine neoplasia type 1. Arch Surg 126:935–946.

    Article  PubMed  CAS  Google Scholar 

  5. Block MA, Frame B, Jackson CF. 1978. The efficacy of subtotal parathyroidectomy for primary hyperparathyroidism due to multiple gland involvement. Surg Gynecol Obstet 147:1–5.

    PubMed  CAS  Google Scholar 

  6. Light GS, Hensley MI. 1986. Management of familial hyperparathyroidism. Prog Surg 18:106–116.

    Google Scholar 

  7. Prinz RA, Gamvros OI, Sellu D, Lynn JA. 1981. Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type 1 syndrome. Ann Surg 193:26–29.

    Article  PubMed  CAS  Google Scholar 

  8. Rizzoli R, Green J III, Marx SJ. 1985. Primary hyperparathyroidism in familial multiple endocrine neoplasia type 1. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med 78:467–474.

    Article  PubMed  CAS  Google Scholar 

  9. Wells SA Jr, Farndon JR, Dale JK, Leight GS, Dilley WG. 1980. Long term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg 192:451–458.

    Article  PubMed  Google Scholar 

  10. van Heerden JA, Kent RB III, Sizemore GW, Grant CS, ReMine WH, Kent RB. 1983. Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndrome. Surgical experience. Arch Surg 118:533–536.

    Article  PubMed  Google Scholar 

  11. Allo M, Thompson NW. 1983. Hyperparathyroidism as a part of MEN 1 syndrome. In Kaplan EL, ed. Surgery of the Thyroid and Parathyroid Glands. Clinical Surgery International. Churchill Livingston, 177–192.

    Google Scholar 

  12. Thompson NW. 1983. The techniques of initial parathyroid exploration and reoperative parathyroidectomy. In Thompson NW, Vinik AI, eds. Endocrine Surgery Update. New York: Grune & Stratton, pp 365–383.

    Google Scholar 

  13. Thompson NW, Eckhauser FE, Harness JK. 1982. Anatomy of primary hyperparathyroidism. Surgery 92:814–822.

    PubMed  CAS  Google Scholar 

  14. Thompson NW. 1995. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 238:269–280.

    Article  PubMed  CAS  Google Scholar 

  15. MacFarlane MP, Fraker DL, Alexander HR, et al. 1995. Perspective study of surgery resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 118:973–980.

    Article  PubMed  CAS  Google Scholar 

  16. Skogseid B, Grama D, Rastad J, et al. 1995. Operative tumor yield obviates preoperative pancreatic tumor localization in multiple endocrine neoplasia type 1. J Intern Med 238:281–288.

    Article  PubMed  CAS  Google Scholar 

  17. Thompson NW, Lloyd RB, Nishiyama RH, Vinik AI, Strodel WE, Allo MD, et al. 1984. MEN-1 pancreas: A histological and immunohistological study. World J Surg 8:561–574.

    Article  PubMed  CAS  Google Scholar 

  18. Shepherd JJ, Challis DR, Davies PF, McArdle JP, Teh BT, Wilkinson S, et al. 1983. Multiple endocrine neoplasia, type 1: Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes and hepatic metastases. Arch Surg 128:1133–1142.

    Article  Google Scholar 

  19. Akerstrom G, Johansson H, Grama D. 1991. Surgical treatment of endocrine pancreatic lesions in MEN 1. Acta Oncol 30:541–545.

    Article  PubMed  CAS  Google Scholar 

  20. Mignon M, Rusziniewski P, Podevin P, et al. 1993. Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia 1. World J Surgery 17:489–497.

    Article  CAS  Google Scholar 

  21. Sheppard BC, Norton JA, Doppman JL, et al. 1989. Management of islet-cell tumors in patients with multiple endocrine neoplasia: A prospective study. Surgery 106:1108–1118.

    PubMed  CAS  Google Scholar 

  22. Kloppel G, Willemer S, Stamm B, Hacki WH, Heitz PU. 1986. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type 1: An immunocytochemical study of nine patients. Cancer 57:1824–1832.

    Article  PubMed  CAS  Google Scholar 

  23. Pipeleers-Marichal M, Somers G, Willems G, Foulis A, Imrie C, Bishop AE, et al. 1990. Gastrinoma in the duodénums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 322:723–727.

    Article  PubMed  CAS  Google Scholar 

  24. Friesen SR. 1990. Are ‘aberrant nodal gastrinomas’ pathogenetically similar to ‘lateral aberrant thyroid’ nodules? Surgery 107:236–238.

    PubMed  CAS  Google Scholar 

  25. Thompson NW. 1992. The surgical treatment of Zollinger-Ellison syndrome in sporadic and MEN 1 syndrome. Acta Chir Austriaca 24:82–87.

    Article  Google Scholar 

  26. Donow C, Pipeleers-Marichal M, Schroder S. 1991. Surgical pathology of gastrinoma: Site, size, multicentricity, association with multiple neoplasia type 1 and malignancy. Cancer 68:1329–1334.

    Article  PubMed  CAS  Google Scholar 

  27. Thompson NW, Bondeson AG, Bondeson L, Vinik AI. 1989. The surgical treatment of gastrinoma in MEN-1 syndrome patients. Surgery 106:1081–1086.

    PubMed  CAS  Google Scholar 

  28. Thompson NW, Pasieka J, Fukuuchi A. 1993. Duodenal gastrinomas, duodentomy and duodenal exploration in the surgical managment of Zollinger-Ellison syndrome. World J Surg 17:455–462.

    Article  PubMed  CAS  Google Scholar 

  29. Pipeleers-Marichal M, Donow C, Heitz PU, Kloppel G. 1993. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type 1. World J Surg 17:481–488.

    Article  PubMed  CAS  Google Scholar 

  30. Delcore R Jr, Cheung LY, Frieson SR. 1990. Characteristics of duodenal wall gastrinomas. Am J Surg 160:621–624.

    Article  PubMed  Google Scholar 

  31. Thorn AK, Norton JA, Axiotis CA, Jenson RT. 1991. Location incidence and malignant potential of duodenal gastrinomas. Surgery 110:1086–1093.

    Google Scholar 

  32. Bornman PC, Marks IN, Mee AS, Price S. 1987. Favorable response to conservative surgery for extra-pancreatic gastrinoma with lymph nodes metastases. Brit J Surg 74:198–201.

    Article  PubMed  CAS  Google Scholar 

  33. Imamura M, Kanda M, Takahashi K, Shimada Y, Miyahara T, Wagata T, et al. 1992. Clinicopathological characteristics of duodenal microgastrinomas. World J Surg 16:703–710.

    Article  PubMed  CAS  Google Scholar 

  34. Thompson NW, Vinik AI, Eckhauser FE. 1989. Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome. Ann Surg 209:396–404.

    Article  PubMed  CAS  Google Scholar 

  35. Delcore R, Herumreck AS, Friesen SR. 1989. Selective surgical management of correctable hypergastrinemia. Surgery 106:1094–1102.

    PubMed  Google Scholar 

  36. Thompson NW. 1992. The surgical treatment of the endocine pancreas and Zollinger-Ellison syndrome in the MEN-1 syndrome. Henry Ford Hosp Med J 40:195–198.

    PubMed  CAS  Google Scholar 

  37. Sugg SL, Norton JA, Fraker DL, Metz DC, Pisegna JR, Fishbeyne V, et al. 1993. A prospective study of intraoperative methods to diagnosis and resect duodenal gastrinomas. Ann Surg 218:138–144.

    Article  PubMed  CAS  Google Scholar 

  38. Cheruer JA, Sawyers JL. 1992. Benefit of resection of metastatic gastrinoma in multiple endocrine neoplasia type 1. Gastroenterology 102:1049–1053.

    Google Scholar 

  39. Norton JA, Doppman JL, Jensen RT. 1992. Curative resection in Zollinger-Ellison syndrome: Results of a 10 year prospective study. Ann Surg 215:8–18.

    Article  PubMed  CAS  Google Scholar 

  40. Tisell LE, Ahlman H, Jansson S, Grimelius L. 1988. Total pancreatectomy in the MEN-1 syndrome. Br J Surg 75:154–157.

    Article  PubMed  CAS  Google Scholar 

  41. van Heerden JA, Smith SL, Miller L. 1986. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. Surgery 100:971–976.

    PubMed  Google Scholar 

  42. Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. 1990. Gastric argyrophil carcoidosis in patients with Zollinger-Ellison syndrome due to type I multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol 14:503–513.

    Article  PubMed  CAS  Google Scholar 

  43. Pasieka JL, McLeod MK, Thompson NW, Burney RE. 1992. Surgical approach to insulinomas: Assessing the need for preoperative localization. Arch Surg 127:442–447.

    Article  PubMed  CAS  Google Scholar 

  44. Service FJ, McMahaon MM, O’Brien PC, Ballard DJ. 1991. Functioning insulinoma-incidence recurrence and long-term survival of patients: A 60-year study. Mayo Clin Proc 66:711–719.

    PubMed  CAS  Google Scholar 

  45. Delcore, Friesen SR. 1992. The role of pancreatoduodenectomy of primary duodenal wall gastrinomas in patients with the Zollinger-Ellison syndrome. Surgery 112:1–8.

    Google Scholar 

  46. Imamura M, Takahashi K, Adachi H, Minematsu S, Shimada Y, Naito M, Suzuki T, et al. 1987. Usefulness of selective arterial secretion injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 205:230–236.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Thompson, N.W. (1997). Multiple endocrine neoplasia type I Surgical therapy. In: Arnold, A. (eds) Endocrine Neoplasms. Cancer Treatment and Research, vol 89. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6355-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6355-6_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7919-5

  • Online ISBN: 978-1-4615-6355-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics